<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We describe an 18-year-old woman with <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> whose monozygotic twin sister is as yet an asymptomatic carrier of the <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi>, anticardiolipin, and anti-beta 2 glycoprotein I (beta 2GPI) antibodies </plain></SENT>
<SENT sid="1" pm="."><plain>Serum concentrations of beta 2GPI were <z:mpath ids='MPATH_458'>normal</z:mpath> in the patient and elevated in her sister </plain></SENT>
<SENT sid="2" pm="."><plain>HLA and complement C4 phenotypes showed the presence of class II antigens DR7 and DRw53 and of a C4AQ0 allele </plain></SENT>
<SENT sid="3" pm="."><plain>This supports the theory that a genetic predisposition may influence the appearance of these autoantibodies </plain></SENT>
</text></document>